A detailed history of Northstar Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Northstar Group, Inc. holds 1,065 shares of LLY stock, worth $794,703. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,065
Previous 1,085 1.84%
Holding current value
$794,703
Previous $982,000 3.97%
% of portfolio
0.17%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$772.14 - $960.02 $15,442 - $19,200
-20 Reduced 1.84%
1,065 $943,000
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $32,602 - $44,947
-75 Reduced 6.47%
1,085 $582,000
Q2 2023

Aug 02, 2023

SELL
$350.74 - $468.98 $35,074 - $46,898
-100 Reduced 7.94%
1,160 $544,000
Q1 2023

Apr 27, 2023

BUY
$310.63 - $364.82 $34,169 - $40,130
110 Added 9.57%
1,260 $432,000
Q2 2021

Jul 28, 2021

BUY
$180.55 - $233.54 $207,632 - $268,571
1,150 New
1,150 $264,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northstar Group, Inc. Portfolio

Follow Northstar Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.